OncoveryCare, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
OncoveryCare, Inc. - overview
Established
2021
Location
-, MA, US
Primary Industry
Healthcare Specialists
About
Established in 2021 and based in Sommerville, US, OncoveryCare, Inc. , formerly VivorCare, Inc. operates as a healthcare clinic for oncology patients. Hil Moss (CEO) and Justin Grischkan (CMO) are the co-founders of the company.
In May 2024, OncoveryCare, Inc. raised USD 4. 5 million in seed funding led by 406 Ventures, including Oncology Ventures, Techstars Ventures, The McKay Institute, and Tennessee Oncology. The company provides survivorship care designed to address the challenges faced by cancer survivors.
The firm’s survivorship care service encompasses a range of services, including physical health management, mental health support, and personalized survivorship care planning. OncoveryCare also facilitates navigation to local resources and referrals and offers peer mentorship programs to connect survivors with others who have shared similar experiences. The organization plans to use the May 2024 funding to widen its market presence and accelerate service features and initiatives.
Current Investors
.406 Ventures, Techstars , Oncology Ventures
Primary Industry
Healthcare Specialists
Sub Industries
Hospitals, Oncology/Cancer Treatment
Website
www.oncoverycare.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.